Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|January 1, 1985
The Sunnybrook Gallstone Study: a double-blind controlled trial of chenodeoxycholic acid for gallstone dissolutionM M Fisher, E A Roberts, I E Rosen, et al.
Gastroenterology|November 1, 1988
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosisG Y Minuk, C E Bohme, E Burgess, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 1, 1997
Endoscopists' opinions of indications for upper gastrointestinal endoscopyL R Sutherland, M J Verhoef, J B Meddings, et al.
Gut|December 22, 1999
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsiaN P Breslin, A B Thomson, R J Bailey, et al.
The American Journal of Gastroenterology|May 16, 2000
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleedingG M Van Rosendaal, L R Sutherland, M J Verhoef, et al.
The American Journal of Gastroenterology|December 22, 1998
The utility of endoscopy in the management of patients with gastroesophageal reflux symptomsP K Blustein, P L Beck, J B Meddings, et al.
Inflammatory Bowel Diseases|March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998C Gasche, J Scholmerich, J Brynskov, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's diseaseB G Feagan, W J Sandborn, J P Baker, et al.
Gastroenterology|April 21, 2001
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trialW J Sandborn, B G Feagan, S B Hanauer, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?M R Kilmurry, E J Heathcote, K Cauch-Dudek, et al.
Pageof 11